What were Chemours' Q2 adjusted EPS and how did it compare to analyst expectations?

Chemours reported Q2 adjusted EPS of $0.42 per share, which fell short of the FactSet estimate of $0.50 per share.

What significant legal challenge is Chemours currently facing, as mentioned in the news?

New York's Attorney General has sued Chemours and other companies over 'forever chemicals.'

Chemours Posts Q2 Adjusted EPS $0.42 per Share, vs. FactSet Est of $0.50

Aug 4, 2026

Chemours reported Q2 adjusted earnings per share of $0.42, missing analyst estimates of $0.50. The announcement highlights ongoing legal challenges, including a lawsuit by New York's Attorney General over forever chemicals.

marketscreener.com

The Chemours Company Posts Q2 Adjusted EPS of $0.42, Missing FactSet Estimates

Moomoo

2026-05-06

The Chemours Company Posts Q1 Adjusted EPS of $0.05, Beating FactSet Estimate

2026-05-06

Chemours Reports First Quarter Results

2026-05-06

Chemours Reports Strong Q1 2026 Earnings, Exceeds Expectations

2026-05-06

Earnings Call Transcript: Chemours Co Q1 2026 Beats EPS Forecast, Stock Falls

2026-05-06

Chemours Announces Second Quarter Dividend

2026-05-07

Chemours Reports Q1 Loss of $29 Million Amid Profitability Concerns

2026-05-07

The Chemours Company Reports 2026 Q1 Earnings Results

2026-07-22

Chemours Earnings on Deck as Investors Eye Margin Recovery

2026-07-23

Chemours Announces Q2 Results Webcast on August 5

2026-07-24

Chemours Reports Q4 2023 Earnings, Beating Analyst Expectations

Show all 15 updates

Chemours Posts Q2 Adjusted EPS $0.42 per Share, vs. FactSet Est of $0.50

FAQ